Kwangmin Son, PhD (he/him/his)

CEO
PhAST Corp.

Dr. Kwangmin Son is the co-founder and CEO at PhAST. He is responsible for setting the vision of the company and defining the overall execution strategy from development, launch to scale. He is a recognized AI healthcare expert within the industry and was invited to present at the Presidential Advisory Council (PACCARB) at the Department of Human and Health Services, 4th global AMR Conference, and the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). Dr. Son has a Bachelor's and Master's degree in Mechanical Engineering from Seoul National University, South Korea. He trained as a bioengineer at the interface of mechanical and biological engineering at MIT, where he earned his PhD before becoming an entrepreneur.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 110 - New Antimicrobials and ID Diagnostics in the Pipeline - Diagnostics

  Friday, October 21, 2022
  8:00 AM – 9:00 AM US ET

• 827 - 90-min Phenotypic Antibiotic Susceptibility Test (PhAST) directly from blood culture and urine samples

  Friday, October 21, 2022
  8:00 AM – 8:12 AM US ET